Lunai Bioworks (LNAI) Other Non-Current Liabilities (2012 - 2025)
Lunai Bioworks (LNAI) posted quarterly Other Non-Current Liabilities of $271643.0 for Q2 2025, up 17.4% year-over-year from $231381.0 in Q2 2024, and up 17.4% quarter-over-quarter from $231381.0 in Q2 2024.
Lunai Bioworks (LNAI) Other Non-Current Liabilities (2012 - 2025) Analysis & Trends
Lunai Bioworks' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $271643.0 for Q2 2025.
- In Q2 2025, Other Non-Current Liabilities rose 17.4% year-over-year to $271643.0; the TTM figure through Jun 2025 stood at $271643.0 (up 17.4% YoY), while the FY2025 annual figure was $271643.0, up 17.4% from the prior year.
- Other Non-Current Liabilities for Q2 2025 stood at $271643.0, up from $231381.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $10.3 million in Q1 2022, with the low at $166625.0 in Q2 2022.
- The 4-year median for Other Non-Current Liabilities is $4.5 million (2021), against an average of $4.7 million.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Liabilities jumped 336.41% in 2021, then slumped 97.24% in 2022.
- Lunai Bioworks' Other Non-Current Liabilities stood at $9.0 million in 2021, then tumbled by 98.15% to $166625.0 in 2022, then soared by 38.86% to $231381.0 in 2024, then grew by 17.4% to $271643.0 in 2025.
- Business Quant data shows LNAI's Other Non-Current Liabilities at $271643.0 in Q2 2025, $231381.0 in Q2 2024, and $166625.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 271,643.00 |
| Jun 30, 2024 | 231,381.00 |
| Jun 30, 2022 | 166,625.00 |
| Mar 31, 2022 | 10.31 Mn |
| Dec 31, 2021 | 9.03 Mn |
| Sep 30, 2021 | 8.86 Mn |
| Jun 30, 2021 | 6.04 Mn |
| Mar 31, 2021 | 2.95 Mn |
| Dec 31, 2020 | 2.07 Mn |
| Sep 30, 2020 | 2.76 Mn |
| Jun 30, 2020 | 3.18 Mn |
| Mar 31, 2020 | 2.01 Mn |
| Dec 31, 2019 | 4.32 Mn |
| Sep 30, 2019 | 5.40 Mn |
| Jun 30, 2019 | 5.67 Mn |
| Jun 30, 2018 | 22.89 Mn |
| Dec 31, 2012 | 850,753.00 |